INTRODUCING ATARA BIOTHERAPEUTICS: THE ROLE OF EBV IN MS AND THE PHASE 2 EMBOLD STUDY

Original Date Presented:
Thursday - June 10, 2021 @ 7:00 PM - 8:00 PM


Introducing Atara Biotherapeutics: The Role of EBV in MS and The Phase 2 EMBOLD Study


Watch Video on Demand: Click Here



Presented by:
JONATHAN WILLMER, BSc, MD, FRCPC
Vice President, Clinical Sciences | Atara Bio


AJ JOSHI, MD
Chief Medical Officer | Atara Bio


MARK FREEDMAN, HBSc, MSc, MD, CSPQ, FANA, FAAN, FRCPC
Professor of Medicine (Neurology) | University of Ottawa


SCOTT NEWSOME, DO, MSCS, FAAN
President - CMSC, FCMSC


JUNE HALPER, MSN, APN-C, FAAN, MSCN
CEO - CMSC, IOMSN, MSNICB